GSK 3532795

CAS: 1392312-45-6

Ref. 3D-SFC31245

Produktinformation

• Name: GSK 3532795

Beschreibung

GSK 3532795 is a new drug for the treatment of HIV-1 infection. It is currently in Phase II clinical trials, which are expected to complete by 2020. GSK 3532795 is a novel non-nucleoside reverse transcriptase inhibitor that has been shown to be active against both wild type and M184V mutant strains of HIV-1 and has potent activity in vitro against HIV-1 with reduced susceptibility to other antiretroviral drugs. This drug also inhibits the expression of CXCR4 and CCR5 co-receptors, which may play an important role in viral entry into CD4+ T cells.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 691 g/mol
• Formel: C₄₂H₆₂N₂O₄S
• Reinheit: Min. 95%